Humana (NYSE:HUM) announced a quarterly dividend on Thursday, April 19th, RTT News reports. Stockholders of record on Friday, June 29th will be paid a dividend of 0.50 per share by the insurance provider on Friday, July 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.68%.
Humana has raised its dividend payment by an average of 10.6% per year over the last three years and has increased its dividend annually for the last 7 consecutive years. Humana has a dividend payout ratio of 13.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Humana to earn $16.60 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 9.6%.
Shares of NYSE:HUM traded down $3.30 on Thursday, reaching $295.00. 434,494 shares of the company traded hands, compared to its average volume of 1,072,837. Humana has a fifty-two week low of $210.01 and a fifty-two week high of $299.67. The company has a market capitalization of $40,794.48, a PE ratio of 25.19, a price-to-earnings-growth ratio of 1.60 and a beta of 0.97. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.85 and a current ratio of 1.85.
Humana (NYSE:HUM) last released its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.00 by $0.06. The company had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.34 earnings per share. research analysts forecast that Humana will post 13.86 EPS for the current fiscal year.
In other Humana news, SVP Cynthia H. Zipperle sold 1,196 shares of the stock in a transaction on Friday, March 9th. The shares were sold at an average price of $273.33, for a total transaction of $326,902.68. Following the transaction, the senior vice president now directly owns 7,771 shares of the company’s stock, valued at $2,124,047.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider M Todoroff Christopher sold 16,389 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $273.37, for a total transaction of $4,480,260.93. Following the transaction, the insider now directly owns 13,447 shares in the company, valued at $3,676,006.39. The disclosure for this sale can be found here. Insiders sold 31,660 shares of company stock worth $8,668,218 over the last ninety days. 0.60% of the stock is currently owned by company insiders.
A number of analysts have recently issued reports on the company. Zacks Investment Research lowered Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 13th. JPMorgan Chase increased their target price on Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a report on Monday, February 12th. Piper Jaffray restated a “buy” rating and issued a $313.00 target price on shares of Humana in a report on Wednesday, April 4th. Deutsche Bank increased their target price on Humana from $259.00 to $270.00 and gave the company a “hold” rating in a report on Friday, February 9th. Finally, Jefferies Group upgraded Humana from a “hold” rating to a “buy” rating and set a $221.00 target price for the company in a report on Friday, January 12th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Humana presently has a consensus rating of “Buy” and an average price target of $277.05.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.